BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 41 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $728 | -85.9% | 3,640 | +45.6% | 0.00% | – |
| Q2 2023 | $5,150 | -79.2% | 2,500 | -66.7% | 0.00% | – |
| Q1 2023 | $24,750 | +101.2% | 7,500 | 0.0% | 0.00% | – |
| Q4 2022 | $12,300 | -62.7% | 7,500 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | +50.0% | 7,500 | -3.8% | 0.00% | – |
| Q2 2022 | $22,000 | -15.4% | 7,795 | +1.2% | 0.00% | – |
| Q1 2022 | $26,000 | -55.2% | 7,706 | -46.5% | 0.00% | – |
| Q4 2021 | $58,000 | +56.8% | 14,407 | +30.9% | 0.00% | – |
| Q3 2021 | $37,000 | -31.5% | 11,008 | -21.4% | 0.00% | – |
| Q2 2021 | $54,000 | -14.3% | 14,008 | -14.1% | 0.00% | – |
| Q1 2021 | $63,000 | +23.5% | 16,298 | +43.9% | 0.00% | – |
| Q4 2020 | $51,000 | -64.6% | 11,324 | +33.2% | 0.00% | – |
| Q3 2020 | $144,000 | -24.2% | 8,500 | -49.8% | 0.00% | – |
| Q2 2020 | $190,000 | +1483.3% | 16,945 | +577.8% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 2,500 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +10.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | -50.0% | 2,500 | -50.7% | 0.00% | – |
| Q2 2019 | $20,000 | +185.7% | 5,068 | +159.5% | 0.00% | – |
| Q4 2018 | $7,000 | +250.0% | 1,953 | +274.9% | 0.00% | – |
| Q3 2018 | $2,000 | -60.0% | 521 | -66.4% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 1,551 | -18.4% | 0.00% | – |
| Q4 2017 | $7,000 | -58.8% | 1,900 | -53.1% | 0.00% | – |
| Q3 2017 | $17,000 | +88.9% | 4,053 | +83.1% | 0.00% | – |
| Q2 2017 | $9,000 | -64.0% | 2,213 | -62.0% | 0.00% | – |
| Q1 2017 | $25,000 | +1150.0% | 5,823 | +547.0% | 0.00% | – |
| Q4 2016 | $2,000 | -84.6% | 900 | -83.3% | 0.00% | – |
| Q2 2016 | $13,000 | +333.3% | 5,385 | +430.0% | 0.00% | – |
| Q4 2015 | $3,000 | +50.0% | 1,016 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -50.0% | 1,016 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | -78.9% | 1,016 | -75.8% | 0.00% | – |
| Q1 2015 | $19,000 | +533.3% | 4,203 | +531.1% | 0.00% | – |
| Q4 2014 | $3,000 | – | 666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |